[225Ac]Ac-AKY-2519 (therapeutic)
AKY-2519-01
Phase 1 small_molecule active
Quick answer
[225Ac]Ac-AKY-2519 (therapeutic) for Castration Resistant Metastatic Prostate Cancer is a Phase 1 program (small_molecule) at Aktis Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aktis Oncology
- Indication
- Castration Resistant Metastatic Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active